Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157294661> ?p ?o ?g. }
- W2157294661 endingPage "1701" @default.
- W2157294661 startingPage "1691" @default.
- W2157294661 abstract "The prostate gland is a rich source of alpha1-adrenergic receptors (alpha1-ARs). alpha1-AR antagonists are commonly used in the treatment of benign prostatic hyperplasia symptoms, due to their action on smooth muscle cells. However, virtually nothing is known about the role of alpha1-ARs in epithelial cells. Here, by using two human prostate cancer epithelial (hPCE) cell models - primary cells from resection specimens (primary hPCE cells) and an LNCaP (lymph node carcinoma of the prostate) cell line - we identify an alpha1A subtype of adrenergic receptor (alpha1A-AR) and show its functional coupling to plasmalemmal cationic channels via direct diacylglycerol (DAG) gating. In both cell types, agonist-mediated stimulation of alpha1A-ARs and DAG analogues activated similar cationic membrane currents and Ca(2+) influx. These currents were sensitive to the alpha1A-AR antagonists, prazosin and WB4101, and to transient receptor potential (TRP) channel blockers, 2-aminophenyl borate and SK&F 96365. Chronic activation of alpha1A-ARs enhanced LNCaP cell proliferation, which could be antagonized by alpha1A-AR and TRP inhibitors. Collectively, our results suggest that alpha1-ARs play a role in promoting hPCE cell proliferation via TRP channels." @default.
- W2157294661 created "2016-06-24" @default.
- W2157294661 creator A5000634668 @default.
- W2157294661 creator A5007220163 @default.
- W2157294661 creator A5013979737 @default.
- W2157294661 creator A5050432911 @default.
- W2157294661 creator A5051373681 @default.
- W2157294661 creator A5052940314 @default.
- W2157294661 creator A5060173638 @default.
- W2157294661 creator A5073247738 @default.
- W2157294661 creator A5073317781 @default.
- W2157294661 creator A5079972049 @default.
- W2157294661 creator A5085997106 @default.
- W2157294661 date "2003-06-01" @default.
- W2157294661 modified "2023-10-18" @default.
- W2157294661 title "α1-adrenergic receptors activate Ca2+-permeable cationic channels in prostate cancer epithelial cells" @default.
- W2157294661 cites W109614840 @default.
- W2157294661 cites W127934333 @default.
- W2157294661 cites W1486952607 @default.
- W2157294661 cites W1497166977 @default.
- W2157294661 cites W1640337403 @default.
- W2157294661 cites W1841809633 @default.
- W2157294661 cites W1889047426 @default.
- W2157294661 cites W1965186415 @default.
- W2157294661 cites W1967156349 @default.
- W2157294661 cites W1969597161 @default.
- W2157294661 cites W1973109917 @default.
- W2157294661 cites W1978115491 @default.
- W2157294661 cites W1996024251 @default.
- W2157294661 cites W1996388831 @default.
- W2157294661 cites W1999502077 @default.
- W2157294661 cites W1999855702 @default.
- W2157294661 cites W2010795846 @default.
- W2157294661 cites W2018533735 @default.
- W2157294661 cites W2023571093 @default.
- W2157294661 cites W2035366125 @default.
- W2157294661 cites W2047364183 @default.
- W2157294661 cites W2049332705 @default.
- W2157294661 cites W2050780119 @default.
- W2157294661 cites W2056592298 @default.
- W2157294661 cites W2074993010 @default.
- W2157294661 cites W2098318544 @default.
- W2157294661 cites W2102204826 @default.
- W2157294661 cites W2104536025 @default.
- W2157294661 cites W2126816757 @default.
- W2157294661 cites W2128048468 @default.
- W2157294661 cites W2128158693 @default.
- W2157294661 cites W2134922176 @default.
- W2157294661 cites W2141260882 @default.
- W2157294661 cites W2153571826 @default.
- W2157294661 cites W2157327912 @default.
- W2157294661 cites W2159602317 @default.
- W2157294661 cites W2165491366 @default.
- W2157294661 cites W2166046655 @default.
- W2157294661 cites W2252785765 @default.
- W2157294661 cites W2332004161 @default.
- W2157294661 cites W2339009088 @default.
- W2157294661 cites W2341408221 @default.
- W2157294661 cites W2357807872 @default.
- W2157294661 cites W2414138829 @default.
- W2157294661 cites W4242548946 @default.
- W2157294661 cites W4245034530 @default.
- W2157294661 cites W4249701809 @default.
- W2157294661 cites W4300348607 @default.
- W2157294661 doi "https://doi.org/10.1172/jci16293" @default.
- W2157294661 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/156103" @default.
- W2157294661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12782672" @default.
- W2157294661 hasPublicationYear "2003" @default.
- W2157294661 type Work @default.
- W2157294661 sameAs 2157294661 @default.
- W2157294661 citedByCount "62" @default.
- W2157294661 countsByYear W21572946612013 @default.
- W2157294661 countsByYear W21572946612014 @default.
- W2157294661 countsByYear W21572946612015 @default.
- W2157294661 countsByYear W21572946612016 @default.
- W2157294661 countsByYear W21572946612017 @default.
- W2157294661 countsByYear W21572946612018 @default.
- W2157294661 countsByYear W21572946612019 @default.
- W2157294661 countsByYear W21572946612020 @default.
- W2157294661 countsByYear W21572946612021 @default.
- W2157294661 countsByYear W21572946612022 @default.
- W2157294661 countsByYear W21572946612023 @default.
- W2157294661 crossrefType "journal-article" @default.
- W2157294661 hasAuthorship W2157294661A5000634668 @default.
- W2157294661 hasAuthorship W2157294661A5007220163 @default.
- W2157294661 hasAuthorship W2157294661A5013979737 @default.
- W2157294661 hasAuthorship W2157294661A5050432911 @default.
- W2157294661 hasAuthorship W2157294661A5051373681 @default.
- W2157294661 hasAuthorship W2157294661A5052940314 @default.
- W2157294661 hasAuthorship W2157294661A5060173638 @default.
- W2157294661 hasAuthorship W2157294661A5073247738 @default.
- W2157294661 hasAuthorship W2157294661A5073317781 @default.
- W2157294661 hasAuthorship W2157294661A5079972049 @default.
- W2157294661 hasAuthorship W2157294661A5085997106 @default.
- W2157294661 hasBestOaLocation W21572946611 @default.
- W2157294661 hasConcept C121608353 @default.
- W2157294661 hasConcept C126322002 @default.
- W2157294661 hasConcept C134018914 @default.